Meta, U.S. States Discuss Settlement in Teen Addiction Trial 
Countries Tighten Social Media Bans for Children 
Nvidia Reportedly Eyes $13 Billion Hugging Face Acquisition 
New Zealand Moves to Ban Social Media for Children Under 16 
U.S. Probes Apex Logistics Over Nvidia AI Chip Shipments to China 
BofA Names ASML Top Semiconductor Equipment Pick on Growth, Valuation 
SoftBank Plans Record $6.3 Billion Bond Sale to Fund OpenAI Investments 
Alibaba Raises $10.2 Billion to Expand AI Infrastructure 
Nvidia Options Price in $280 Billion Earnings Swing 
Google Expands Gemini Enterprise With AI Tools for Legal Sector 
PayPal Shares Sink as $50 Billion Takeover Bid Collapses 
Nvidia Pauses AI Cloud Financing Deals Amid Antitrust Concerns 
OpenAI AI Agent Swarm Behind Hugging Face Hack 
SoftBank Eyes $20 Billion Bond Sale to Refinance OpenAI Loan 
Pinterest Stock Falls as CFO Julia Brau Donnelly Resigns 
Add as a preferred source on Google
In what appears to be a strategic move to diversify its business, Alphabet Inc has relaunched its Life Sciences division as a new spinoff company known as Verily. In an introductory video, former Google showed that Verily will be focusing more on health sciences and how it will provide solutions or studies to combat or manage diseases, the Verge notes. Its standalone website, verily.com, is also live as well.
"As a life sciences team within Google[x], we were able to combine the best of our technology heritage with expertise from across many fields. Now, as an independent company, Verily is focused on using technology to better understand health, as well as prevent, detect, and manage disease," the website read.
Endgadget said that the new Verily is working on more wearables, among other projects, to achieve their goals. One goal is reportedly using wearables to detect cancer cells at very early stages in patients. Verily is also targeting to partner with third-party firms who have the technology to help the former achieve its goals.
